Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (179)	3/17/1998 9:40:00 AM
From: yehuda fruchter	Read Replies (1) \| Respond to of 471

That is ridiculous. Why would STJ buy CYBX before? The technology was unproven and the market untested. CYBX has only been selling this thing for less than a year, so it will still take some time before the technological feasibility and marketability of vagus nerve stimulation(that is the real new technology for CYBX) is certain. And once more, who cares how many shares are up for sale or who is marketing the stock, noone can fight fundamentals and if CYBX keeps its sales momentum up its stock will go up.